Skip to content

Electrophysiological Study on the Dominant Motor Innervation of the Brachial Plexus Nerve and Its Clinical Significance

Electrophysiological Study on the Dominant Motor Innervation of the Brachial Plexus Nerve and Its Clinical Significance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106758
Enrollment
Unknown
Registered
2025-07-30
Start date
2025-07-30
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachial plexus nerve injury

Interventions

CC7 displacement observation group:None

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with definite diagnosis of brachial plexus root avulsion injury; 2.Gender is not limited; 3. Age of 18-60 years old; 4.The symptomatic diagnosis was total brachial plexus root avulsion, and the nerve injury location was consistent with neuroelectrophysiology and imaging. 5.Those who failed to respond to formal conservative treatment; 6.No definite contraindications to surgery; 7.The patient was informed and agreed to enter this study.

Exclusion criteria

Exclusion criteria: 1. Muscle loss of nervation for a long time, more than 18 months; 2. Combined fracture of the affected limb; 3. Patients with inflammation or infection in the surgical area; 4. Patients who do not have the ability to act independently; 5. Patients with uncontrolled active infection throughout the system; 6. Patients with other diseases that do not allow surgical treatment; 7. Patients with other brain, spinal cord, and peripheral neuropathy that may interfere with clinical evaluation; Patients need to sign the informed consent form before surgery, and patients who do not agree to sign will be removed from the group and postponed to the next one.

Design outcomes

Primary

MeasureTime frame
Intraoperative CMAP amplitude;

Secondary

MeasureTime frame
Muscle strength of the affected limb;

Countries

China

Contacts

Public ContactWenjun Li

Beijing Jishuitan Hospital

dcliwenjun@163.com+86 139 1045 2661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026